Abstract:Alnustone‐targeted CrtN blocked staphyloxanthin (STX) formation and elucidated its mechanism of action and in vivo therapeutic effects. Background and Purpose At present, the inhibition of staphyloxanthin biosynthesis has emerged as a prominent strategy in combating methicillin‐resistant Staphylococcus aureus (MRSA) infection. Nonetheless, there remains a limited understanding regarding the bio‐structural characteristics of staphyloxanthin biosynthetic enzymes, as well as the molecular mechanisms underlying the interaction between inhibitors and proteins. Furthermore, the functional scope of these inhibitors is relatively narrow. Experimental Approach In this study, we address these limitations by harnessing the power of deep learning techniques to construct the 3D structure of diapophytoene desaturase (CrtN). We perform efficient virtual screening and unveil alnustone as a potent inhibitor of CrtN. Further investigations employing molecular modelling, site‐directed mutagenesis and biolayer interferometry (BLI) confirmed that alnustone binds to the catalytic active site of CrtN. Transcriptomic analysis reveals that alnustone significantly down‐regulates genes associated with staphyloxanthin, histidine and peptidoglycan biosynthesis. Key Results Under the effects of alnustone, MRSA strains exhibit enhanced sensitivity to various antibiotics and the host immune system, accompanied by increased cell membrane permeability. In a mouse model of systemic MRSA infection, the combination of alnustone and antibiotics exhibited a significant therapeutic effect, leading to reduced bacterial colony counts and attenuated pathological damage. Conclusion and Implications Alnustone, as a natural inhibitor targeting CrtN, exhibits outstanding antibacterial properties that are single‐targeted yet multifunctional. This finding provides a novel strategy and theoretical basis for the development of drugs targeting staphyloxanthin producing bacteria.

Novel Staphyloxanthin Inhibitors with Improved Potency Against Multidrug Resistant Staphylococcus Aureus.

Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin Versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus Aureus Infections in Vivo

Novel Terminal Bipheny-Based Diapophytoene Desaturases (crtn) Inhibitors As Anti-MRSA/VISR/LRSA Agents with Reduced Herg Activity.

Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (crtn) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections.

Discovery of Novel Piperonyl Derivatives As Diapophytoene Desaturase Inhibitors for the Treatment of Methicillin-, Vancomycin- and Linezolid-Resistant Staphylococcus Aureus Infections

Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections

Capsaicin Derivatives with Nitrothiophene Substituents: Design, Synthesis and Antibacterial Activity Against Multidrug-Resistant S. Aureus.

Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN).

Small-molecule Targeting of a Diapophytoene Desaturase Inhibits S. Aureus Virulence.

Novel Fluorinated Pyrrolomycins As Potent Anti-Staphylococcal Biofilm Agents: Design, Synthesis, Pharmacokinetics and Antibacterial Activities.

A natural inhibitor of diapophytoene desaturase attenuates methicillin‐resistant Staphylococcus aureus (MRSA) pathogenicity and overcomes drug‐resistance

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

Design and synthesis of novel anti-multidrug-resistant staphylococcus aureus derivatives of glycyrrhetinic acid by blocking arginine biosynthesis, metabolic and H2S biogenesis

Discovery of novel dihydropyrrolidone-thiadiazole compound crosstalk between the YycG/F two-component regulatory pathway and cell membrane homeostasis to combat methicillin-resistant Staphylococcus aureus

Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant <i>Staphylococcus</i> <i>aureus</i>

Design, Synthesis, in Vitro and in Vivo Evaluation and Molecular Docking Study of Novel Pleuromutilin Derivatives As Antibacterial Agents

Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents

Synthesis and antibacterial evaluation of novel psoralen derivatives against methicillin‐resistant Staphylococcus aureus (MRSA)

Discovery and Optimization of Novel SaFabI Inhibitors As Specific Therapeutic Agents for MRSA Infection.